->

Isigaba: I-Cancer Cancer

Ikhaya / Unyaka Omisiwe

, ,

I-Cabozantinib ivunyelwe umdlavuza we-thyroid ohlukile

Okthoba 2021: I-Cabozantinib (Cabometyx, Exelixis, Inc.) igunyazwe i-Food and Drug Administration kuziguli ezikhulile kanye nezingane ezineminyaka engu-12 ubudala nangaphezulu eziye zahlukanisa i-thyroi ethuthukisiwe endaweni noma ye-metastatic.

Umuthi olwa nomdlavuza uLenvatinib ugunyaze ukwelashwa komdlavuza wegilo

I-Lenvatinib (Lenvima) Isidakamizwa esisha somdlavuza womlomo i-Lenvima (lenvatinib) sisanda kugunyazwa yi-Japan ukuze zelashwe umdlavuza wegilo ongalungiseki. Lena enye imakethe ebalulekile isidakamizwa esiyithathile kusukela saba uhlelo lokusebenza..

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton